報價延遲最少15分鐘:2025/01/21 08:56 EST
|
|
|
|
|
||||||||||||
|
|
|
|
|
-- 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-0.28/-0.03
|
|
企業價值
69.39M
|
| 資產負債 |
|
每股賬面淨值
0.18
|
| 現金流量 |
|
現金流量率
--
|
| 損益表 |
|
收益
3.23M
|
|
每股收益
0.06
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘：2025/01/21 08:56 EST
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in the breast, lungs, kidneys, bones, and other indications. |